X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2025)
X4 Pharmaceuticals (XFOR) posted Tax Provisions of -$30000.0 for Q3 2025, down 181.08% on a QoQ basis from $37000.0 in Q2 2025, and down 300.0% year-over-year from $15000.0 in Q3 2024.
X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2025) Analysis & Trends
X4 Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at -$30000.0 for Q3 2025.
- Quarterly Tax Provisions fell 300.0% year-over-year to -$30000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $41000.0 (down 86.77% YoY) and the FY2025 annual result came in at $41000.0, down 86.77% from the prior year.
- Tax Provisions was -$30000.0 for Q3 2025 at X4 Pharmaceuticals, down from $37000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $258000.0 in Q4 2024 and bottomed at -$30000.0 in Q3 2025.
- A 5-year average of $24947.4 and a median of $15000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 750.0% — and 2024, when it surged 681.82%.
- X4 Pharmaceuticals' Tax Provisions stood at $3000.0 in 2021, then soared by 366.67% to $14000.0 in 2022, then jumped by 135.71% to $33000.0 in 2023, then jumped by 681.82% to $258000.0 in 2024, then tumbled by 111.63% to -$30000.0 in 2025.
- Business Quant data shows XFOR's Tax Provisions at -$30000.0 in Q3 2025, $37000.0 in Q2 2025, and $34000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2020 | 148,000.00 |